New Canadian guidelines for managing luminal Crohn’s disease in childrenAim to enhance clinician–patient discussions and help patients make evidence-based informed decisions about their treatment Health Canada warns of possible graft rejection when oral tacrolimus formulations switchedImmediate-, extended- and prolonged-release oral formulations of tacrolimus are not interchangeable Health Canada warns of possible graft rejection when oral tacrolimus formulations switched Immediate-, extended- and prolonged-release oral formulations of tacrolimus are not interchangeable Splitting laxative dose better for colonoscopy polyp detection Researchers suggest abandoning one-dose, day-before bowel preparation regimens PPI use alone or with an H2 blocker in infants associated with elevated risk of childhood fracture Study suggests risk increases with duration of use and earlier initiation of acid suppressive therapy Diarrhea associated with antibiotics: probiotics offer some protection for children Pharmacists regularly asked for advice on managing common gastrointestinal disorders in infants Parents often consult pharmacists to obtain information on infant colic, gastroesophageal reflux and constipation Antibiotic use in infants may be linked to development of celiac disease in childhood Study finds early exposure to systemic antibiotics might be a risk factor for celiac disease Canada to study the safety and effectiveness of biosimilars compared to reference biologic drugs Five-year study will examine real-world comparative efficacy and safety in rheumatologic conditions and inflammatory bowel disease. New Canadian consensus guidelines for managing irritable bowel syndrome Aim to help optimize the use of existing medical therapies and their sequence of use First Previous 9 10 11 12 13 Next Last
